Dermatology Times

Dermatology Times is a weekly publication that serves as a key resource for dermatologists. It provides trustworthy, pertinent, and up-to-date coverage of the newest developments in the field of dermatology.

National, Trade/B2B

English

Magazine

Outlet metrics

Domain Authority

Ranking

Global

#251550

United States

#100692

Health/Medicine

#887

Traffic sources

Monthly visitors

Articles

AI Model Creates Successful Treatment Regimens for Women with Hair Loss

4 days ago | dermatologytimes.com | Marie Bosslett

In a recent study, clinicians were able to create personalized treatments for patients with hair loss based on artificial intelligence (AI).1 The AI platform, developed by MDalgorithms, Inc., was able to recommend therapies that greatly improved hair growth, thickness, fullness, volume, and coverage over 6 months.
The Weekly Roundup: May 5-9

5 days ago | dermatologytimes.com | Marie Bosslett

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters. How OX40-Targeted Therapies Might Reshape Biologic Strategy in ADChristopher Bunick, MD, PhD, discusses the evolving role of OX40-targeted biologics in atopic dermatitis treatment ahead of the upcoming RAD conference.
Dermatology Times Spot Test: May 10, 2025

6 days ago | dermatologytimes.com | Emma Andrus

Dermatology Times presents: Spot Test!Each week, dive into a series of thought-provoking questions designed to test your understanding of essential topics, trends, and breakthroughs in dermatology. This week, we’ll focus on the critical intersections between dermatologic conditions and psychological well-being in recognition of Mental Health Awareness Month. Do you have a set of quiz questions to share?
Collaborating for Better Aesthetics: Why Dermatology Matters in Multispecialty Medicine

6 days ago | dermatologytimes.com | Emma Andrus

In a world where medicine continues to evolve rapidly across specialties, one thing remains constant: patients are more informed, curious, and discerning than ever before. In dermatology, arguably one of the most visual and patient-facing specialties, this creates opportunity and challenge. For S.
Artax Presents Phase 2a Results of AX-158 for Plaque Psoriasis

6 days ago | dermatologytimes.com | Marie Bosslett

At the Society for Investigative Dermatology 2025 Annual Meeting in San Diego, California, Artax Biopharma shared Phase 2a late-breaking trial results (NCT05725057) of AX-158, a first-in-class oral Nck modulator for patients with mild to moderate plaque psoriasis.1 “We’re highly encouraged by the safety profile observed in our Phase 2a study and the notable impact of our oral Nck modulator AX-158 on key disease biomarkers and clinical severity scores,” Rob Armstrong, PhD, Chief Executive...
Outgoing AAD President Seemal Desai, MD, FAAD, Reflects on Challenges, Advocacy, and the Future of Dermatology

6 days ago | dermatologytimes.com | Emma Andrus |Seemal R. Desai

Earlier this year, Seemal Desai, MD, FAAD, concluded his term as president of the American Academy of Dermatology (AAD), marking a tenure defined by advocacy, unity, and vision for the future of the specialty. In an exclusive article for Dermatology Times, Desai recently outlined 3 pivotal issues that will shape dermatology in 2025 and beyond: Medicare reimbursement reform, board-certification awareness, and balancing technological advances with patient-centered care.
Study Highlights Unmet Needs in Measuring Patient Experiences in Alopecia Areata

1 week ago | dermatologytimes.com | Cameron Santoro

In robust validation studies that assess the internal structure of patient-reported outcome measures (PROMs) for alopecia areata (AA), significant gaps highlight unmet needs in understanding the patient experience with this common hair loss condition, according to a study published in JAMA Dermatology.1AA is a common immune-mediated disease, classified as a dermatological condition, that causes nonscarring hair loss on the scalp and other hair bearing sites on the body.
Daily Derm Times: May 8, 2025

1 week ago | dermatologytimes.com | Emma Andrus

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters. The Clinical Image Collection enhances dermatologic education by providing diverse images of skin conditions, promoting inclusivity and accurate diagnoses across all skin tones. New research from AAD 2025 highlights upadacitinib's effectiveness over dupilumab for treating atopic dermatitis, especially in challenging facial and neck areas.
Corvus Pharmaceuticals’ Soquelitinib Shows Rapid, Dose-Dependent Efficacy in Phase 1 AD Trial

1 week ago | dermatologytimes.com | Kaitlyn Bader

Corvus Pharmaceuticals recently announced new interim data for its randomized, double-blind, placebo-controlled phase 1 clinical trial evaluating soquelitinib in patients with moderate to severe atopic dermatitis (AD) who have failed one prior topical or systemic therapy.
#DermTok: Navigating TikTok’s Acne Advice Misinformation

1 week ago | dermatologytimes.com | Marie Bosslett

As TikTok and other social media platforms continue to influencehow patients seek dermatologic advice—particularly around acne—clinicians are confronting online misinformation. While the hashtag #DermTok garners billions of views, studies show the majority of popular videos lack clinical accuracy, prompting calls for more evidence-based content from board-certified professionals like Chris Tomassian, MD, and Adam Friedman, MD, FAAD.